Literature DB >> 23263896

FDA regulation of cardiovascular devices and opportunities for improvement.

Sanket S Dhruva1, Rita F Redberg.   

Abstract

Medical devices are of increasing importance in cardiovascular disease and have made important contributions to patient care. These devices continue to evolve with increasing complexity. FDA regulation of medical devices involves increased stringency for higher risk and novel devices. However, there are some current opportunities to strengthen the FDA's pre-approval regulatory process and improve post-marketing surveillance. This article reviews FDA regulation of cardiovascular devices and offers suggestions for strengthening the process while focusing on examples relevant to cardiac electrophysiologists.

Entities:  

Mesh:

Year:  2012        PMID: 23263896     DOI: 10.1007/s10840-012-9767-1

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  35 in total

1.  Rational dispersion for the introduction of transcatheter valve therapy.

Authors:  Michael J Mack; David R Holmes
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272

2.  Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies.

Authors:  Connie E Chen; Sanket S Dhruva; Lisa A Bero; Rita F Redberg
Journal:  Arch Intern Med       Date:  2010-11-22

3.  Accelerated approval and possible withdrawal of midodrine.

Authors:  Sanket S Dhruva; Rita F Redberg
Journal:  JAMA       Date:  2010-11-17       Impact factor: 56.272

4.  Left atrial appendage occlusion--closure or just the beginning?

Authors:  William H Maisel
Journal:  N Engl J Med       Date:  2009-05-27       Impact factor: 91.245

5.  The deregulatory effects of preempting tort litigation: FDA regulation of medical devices.

Authors:  Lawrence O Gostin
Journal:  JAMA       Date:  2008-05-21       Impact factor: 56.272

6.  Medical devices and health--creating a new regulatory framework for moderate-risk devices.

Authors:  David R Challoner; William W Vodra
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

7.  Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices.

Authors:  Frederic S Resnic; Thomas P Gross; Danica Marinac-Dabic; Nilsa Loyo-Berrios; Sharon Donnelly; Sharon-Lise T Normand; Michael E Matheny
Journal:  JAMA       Date:  2010-11-10       Impact factor: 56.272

8.  Composite outcomes in cardiovascular research: a survey of randomized trials.

Authors:  Eric Lim; Adam Brown; Adel Helmy; Shafi Mussa; Douglas G Altman
Journal:  Ann Intern Med       Date:  2008-11-04       Impact factor: 25.391

9.  Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Authors:  Hamid Ghanbari; Ghassan Dalloul; Reema Hasan; Marcos Daccarett; Souheil Saba; Shukri David; Christian Machado
Journal:  Arch Intern Med       Date:  2009-09-14

10.  Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.

Authors:  Pamela N Peterson; Stacie L Daugherty; Yongfei Wang; Humberto J Vidaillet; Paul A Heidenreich; Jeptha P Curtis; Frederick A Masoudi
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

View more
  2 in total

1.  Introduction: health policy II. A new era of heath policy in electrophysiology and cardiology.

Authors:  Fred Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2016-09-16       Impact factor: 1.900

2.  An in Vitro Twist Fatigue Test of Fabric Stent-Grafts Supported by Z-Stents vs. Ringed Stents.

Authors:  Jing Lin; Robert Guidoin; Jia Du; Lu Wang; Graeham Douglas; Danjie Zhu; Mark Nutley; Lygia Perron; Ze Zhang; Yvan Douville
Journal:  Materials (Basel)       Date:  2016-02-16       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.